{{Rsnum
|rsid=7956547
|Gene=IGF1
|Chromosome=12
|position=102465038
|Orientation=plus
|GMAF=0.2277
|Gene_s=IGF1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.6 | 34.5 | 54.9
| HCB | 0.7 | 29.2 | 70.1
| JPT | 3.5 | 33.6 | 62.8
| YRI | 8.2 | 39.0 | 52.7
| ASW | 12.3 | 56.1 | 31.6
| CHB | 0.7 | 29.2 | 70.1
| CHD | 0.9 | 29.6 | 69.4
| GIH | 3.0 | 26.7 | 70.3
| LWK | 13.8 | 45.0 | 41.3
| MEX | 0.0 | 29.3 | 70.7
| MKK | 3.2 | 37.2 | 59.6
| TSI | 4.0 | 35.6 | 60.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=23113306
|Title=Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors
}}

{{PMID Auto
|PMID=18199734
|Title=IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study.
|OA=1
}}

{{PMID Auto
|PMID=18772892
|Title=Can genes for mammographic density inform cancer aetiology?
|OA=1
}}

{{PMID Auto
|PMID=19240240
|Title=IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
|OA=1
}}

{{PMID Auto
|PMID=21113804
|Title=IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.
}}

{{PMID Auto
|PMID=24640097
|Title=Associations of single nucleotide polymorphisms with malignant and borderline bone tumors
}}

{{on chip | Affy GenomeWide 6}}